Home » Drug Information » Recently Approved Drugs » 1999
Medical Areas: Endocrinology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Roche
Approval Status: Approved April 1999
Treatment Area: Endocrinology
Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been
approved for obesity management. Xenical acts by inhibiting the
absorption of dietary fats.